MedPath

The NIFTY study: A Multi-centre Randomised Double Blind Placebo Controlled Trial of Nifedipine Maintenance Tocolysis in Fetal Fibronectin Positive Women in Threatened Preterm Labour

Completed
Conditions
Preterm Labour
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Registration Number
ACTRN12613000985785
Lead Sponsor
Emma Parry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria

Women with threatened preterm labour, a singleton pregnancy, gestational age between 24 and 34 weeks, intact membranes, positive fetal fibronectin test, completed course of corticosteroids

Exclusion Criteria

Ruptured membranes, suspicion of chorioamnionitis, antepartum haemorrhage or suspected concealed abruption, major fetal anomaly, contraindication to nifedipine treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of pregnancy, time between randomisation and delivery.[End of pregnancy, defined as date of delivery]
Secondary Outcome Measures
NameTimeMethod
Reduction of neonatal admission by greater than 4 days[At discharge from neonatal admission unit, duration of neonatal admission defined by discharge date minus admission date]
© Copyright 2025. All Rights Reserved by MedPath